CONMED Announces Resignation of Company's CONMED Linvatec Subsidiary President
Conmed zu myNews hinzufügen Was ist das?
CONMED Corporation (Nasdaq: CNMD) announced today that Mr. Gerald G.
Woodard, President of the Company’s CONMED
Linvatec subsidiary has resigned, effective January 30, 2008, to become
CEO of SRI Surgical, a publicly traded company that provides central
processing and supply chain management services to hospitals and surgery
centers. CONMED has begun a search for his successor. In the interim,
Mr. Joseph J. Corasanti, CEO and President of CONMED, will lead the
management team of CONMED Linvatec, based in Largo, Florida.
"This is a wonderful opportunity for Gerald
and all of us within the CONMED organization wish him success in his
future endeavors. Over the past seven years, Gerald has supervised the
Company’s orthopedic product offering and
developed an organization built on customer service. We are confident
that this change will have no material affect on our business, and I
look forward to working closely with our orthopedic team while we search
for the most appropriate candidate,” noted Mr.
Corasanti.
CONMED Profile
CONMED is a medical technology company with an emphasis on surgical
devices and equipment for minimally invasive procedures and patient
monitoring. The Company’s products serve the
clinical areas of sports medicine-arthroscopy, powered surgical
instruments, electrosurgery, cardiac monitoring disposables, endosurgery
and endoscopic technologies. Surgeons and physicians in a variety of
specialties including orthopedics, general surgery, gynecology,
neurosurgery, and gastroenterology use the Company’s
medical devices. Headquartered in Utica, New York, the Company’s
3,200 employees distribute its products worldwide from several
manufacturing locations.
Forward Looking Information This press release contains forward-looking statements based on
certain assumptions and contingencies that involve risks and
uncertainties. The forward-looking statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 and relate to the Company’s
performance on a going-forward basis. The forward-looking
statements in this press release involve risks and uncertainties which
could cause actual results, performance or trends, to differ materially
from those expressed in the forward-looking statements herein or in
previous disclosures. The Company believes that all
forward-looking statements made by it have a reasonable basis, but there
can be no assurance that management’s
expectations, beliefs or projections as expressed in the forward-looking
statements will actually occur or prove to be correct.
